PLYX

Polaryx Therapeutics, Inc.

6.36

+1.71+36.77%

After Hours: 6.00 -0.36 -5.66%19:59 03/13 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE4.560/4.650

TODAY RANGE4.340-7.09

VOL7.83M

MARKET CAP301.10M

52 WEEK RANGE2.201-48.91

AVG VOL (3M)3.41M

% TURNOVER16.55%

TURNOVER--

P/E (TTM)-139.7802

% RANGE59.14%

EPS(TTM)-0.0455

P/E(FORWARD)-33.4737

P/B56.79

BVPS0.1120

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP301.10M

SHARES OUTSTANDING47.34M

NEXT EARNINGS--

FREE FLOAT47.34M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·3d ago
Polaryx Therapeutics, Inc trading resumes
TipRanks·3d ago
Polaryx Therapeutics, Inc trading halted, volatility trading pause
Reuters·3d ago
Polaryx Therapeutics to attend Krabbe Translational Research Network meeting and Putt-Putt to #CureKrabbe event
TipRanks·03/02 18:36
Maxim Group Initiates a Buy Rating on Polaryx Therapeutics, Inc. (PLYX)
Dow Jones·02/27 21:38
Polaryx Therapeutics Initiated at Buy by Maxim Group
Dow Jones·02/27 21:38
Polaryx Therapeutics Price Target Announced at $10.00/Share by Maxim Group
TipRanks·02/27 14:09
Maxim starts Polaryx at Buy, sees PLX-200 as differentiated
TipRanks·02/27 13:43
Polaryx commits to patients with rare pediatric lysosomal storage disorders
TipRanks·02/27 13:15
Polaryx initiated with a Buy at Maxim
Reuters·02/20 21:42
Polaryx Therapeutics CFO and Director G. Michael Landis Acquires Common Shares
Dow Jones·02/17 15:44
Polaryx Therapeutics Shares Rise After Selecting Contract Research Organization
NASDAQ·02/17 15:33
Polaryx To Initiate SOTERIA Phase 2 Basket Trial In 1H2026; Stock Up
Reuters·02/17 13:32
POLARYX THERAPEUTICS INC: CONTINUES TO ACTIVELY WORK WITH ITS CONTRACT RESEARCH ORGANIZATION (CRO) TO INITIATE TRIAL IN FIRST HALF OF 2026
Reuters·02/17 13:32
POLARYX THERAPEUTICS SELECTS CONTRACT RESEARCH ORGANIZATION FOR SOTERIA PHASE 2 BASKET TRIAL
Reuters·02/17 13:30
Polaryx Therapeutics selects CRO for SOTERIA Phase 2 trial

Same Industry

Name/Symbol

Change%

Price

REGN

GRDX

BIONTECH

BNTX

+1.21%

91.19

UTHR

VRTX

Siga Technologie

SIGA

-3.84%

5.26

MRNA

CRL

MEDP

TLPH

ICLR

CBPO

IQV

MOLN

Arcturus Therape

ARCT

-4.57%

6.68

GILD

PRAH

INCY

APVO

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.